Shares in financial firm Stifel (SF) dropped 3% today after it was told to cough up $132.5 million in damages to a U.S.

Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million ...

Stock analysts at Stifel Nicolaus initiated coverage on shares of Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) in a research ...

Steward Partners Investment Advisory LLC raised its position in Capital Group U.S. Multi-Sector Income ETF (NYSEARCA:CGMS – Free Report) by 165.5% in the fourth quarter, HoldingsChannel.com reports.

Neumora Therapeutics (NASDAQ:NMRA) fell ~11% in the premarket on Friday as Stifel downgraded the biotech after efficacy concerns prompted J&J (NYSE:JNJ) to discontinue a late-stage program called ...

Stifel initiated coverage of Uranium Energy (UEC) with a Buy rating and $10.50 price target as the firm rolled out coverage on four uranium ...

Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of ...

Fintel reports that on February 27, 2025, Stifel downgraded their outlook for Arko (NasdaqCM:ARKO) from Buy to Hold. Analyst ...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Stifel Financial (SF) have what it takes? Let's find out.

ST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today appointed Jonathan Siegmann as Managing Director of Equity Research, covering the aerospace and defense industry.